Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | AKT1 | P31749 | 1/20 | 0.49 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TGM2 | P21980 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7078462 | 1.00 | LMNA (0.51) | LMNATSHRPRKCAAKT1PTK2 | |
| SCHEMBL5200865 | 0.89 | TSHR (0.48) | LMNATSHRPRKCAAKT1PTK2 | |
| SCHEMBL7075802 | 0.85 | KDM4E (0.47) | LMNATSHRALDH1A1KDM4E | |
| SCHEMBL6690906 | 0.82 | P4HB (0.53) | LMNATSHRPRKCAAKT1PTK2 | |
| Catechol SCHEMBL6657117 | 0.78 | TSHR (0.62) | LMNATSHRPRKCAAKT1PTK2 | |
| SCHEMBL23330709 | 0.76 | CYP2D6 (0.70) | LMNATSHRKMT2ACYP2D6THRB | |
| SCHEMBL3313146 | 0.76 | CYP2D6 (0.70) | LMNATSHRKMT2ACYP2D6THRB | |
| SCHEMBL7153175 | 0.76 | CYP2D6 (0.70) | LMNATSHRKMT2ACYP2D6THRB | |
| SCHEMBL13621664 | 0.76 | CYP2D6 (0.70) | LMNATSHRKMT2ACYP2D6THRB | |
| SCHEMBL20524278 | 0.76 | CYP2D6 (0.70) | LMNATSHRKMT2ACYP2D6THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1252171-B1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | GOEMAR LAB SA (FR) | 2007-08-15 | — | — | EP | disclosed |
| US-20030045706-A1 | Method for preparing functionalised beta-(1,3)-glucan derivatives | LABORATOIRES GOEMAR (FR) | 2003-03-06 | — | — | US | disclosed |
| EP-1252171-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR S.A. (FR) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001057053-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR (FR) | 2001-08-09 | — | — | WO | disclosed |